No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels (2020)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.atherosclerosis.2020.08.004
- Subjects: APOLIPOPROTEÍNAS; COLESTEROL; LIPOPROTEÍNAS HDL; MEIA IDADE; FOSFOLIPÍDEOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 311, p. 13-19, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
ZHENG, Kang H et al. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, v. 311, p. 13-19, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.004. Acesso em: 12 jan. 2026. -
APA
Zheng, K. H., Kaiser, Y., Olden, C. C. van, Santos Filho, R. D. dos, Dasseux, J. -L., Genest, J., et al. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, 311, 13-19. doi:10.1016/j.atherosclerosis.2020.08.004 -
NLM
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004 -
Vancouver
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004 - Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia
- Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia
- Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)
- Check-up e progressão do risco cardiovascular: existe espaço para inovação?
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia Executive summary
- Relation of Physical Activity to Prevalence of Nonalcoholic Fatty Liver Disease Independent of Cardiometabolic Risk
- Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management
- Tratamento das dislipidemias
- Recommendations for the management of patients with familial hypercholesterolemia
- Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglycerid levels in the Arabian Gulf
Informações sobre o DOI: 10.1016/j.atherosclerosis.2020.08.004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
